Jennifer Ernst, who served as lead administrator in the absence of Bill Trankina for much of the last school year, was retained in that position for the 2011-12 year. Jennifer Ernst, who served as ...
SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicine, announced today that CEO Jennifer Ernst will ...
Jennifer Ernst, Rantoul City Schools assistant superintendent, has resigned her position, effective at the conclusion of the 2012-13 school year.That announcement was made at the March 14 RCS school ...
Jennifer Ernst, CEO of Tivic, will deliver a formal presentation detailing the company’s strategic transformation into the biopharmaceutical sector. This evolution positions Tivic as a unique ...
Hosted on MSN
Tivic Health targets FDA approval for Entolimod within 18 months, highlights transformation into biopharma
CEO Jennifer Ernst highlighted significant advancements, including the acquisition of exclusive worldwide rights to the Phase III immunomodulatory drug candidate Entolimod, which aims to treat acute ...
Jennifer Ernst does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Tivic Health Systems, Inc.. Attention insiders: Dive deeper into ...
Bioelectronic Medicine stands to disrupt how we diagnose, treat, and manage disease, but fulfilling that promise requires broad alignment across the healthcare ecosystem. This session will explore how ...
FREMONT, Calif.--(BUSINESS WIRE)-- Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that the company’s CEO will present during the Emerging Growth ...
Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that CEO, Jennifer Ernst, will participate in the eighth annual Constellation Forum, a global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results